Medical Device Testing Market Forecasts to 2030 - Global Analysis By Product, By Service Type, By Sourcing Type, By Device Class, By End User and By Geography

According to Stratistics MRC, the Global Medical Device Testing Market is accounted for $10.9 billion in 2023 and is expected to reach $17.3 billion by 2030 growing at a CAGR of 6.9% during the forecast period. Medical device testing refers to the rigorous evaluation and assessment of medical devices to ensure their safety, efficacy and compliance with regulatory standards. It involves a series of tests, inspections and trials conducted during product development and manufacturing, as well as post-market surveillance. Medical device testing is essential to verify that devices meet quality standards, perform as intended and pose minimal risk to patients.

According to the Center for Medicare & Medicaid Services, the United States healthcare spending grew by 4.6% in 2018, reaching USD 3.6 trillion or USD 11,172 per person.

Market Dynamics:

Driver:

Growing aging population

As the global demographic landscape skews older, there is a parallel increase in healthcare needs. Elderly individuals often require a wide range of medical devices, from orthopedic implants to cardiac devices and mobility aids. To ensure the safety and efficacy of these devices, rigorous testing is essential. Moreover, older patients may be more vulnerable to potential device-related complications, making thorough testing even more critical. The rising demand for medical devices tailored to this demographic underscores the importance of robust testing processes to meet the unique healthcare challenges posed by an aging population.

Restraint:

Increasing complexity of medical devices

As medical technology advances, devices are becoming more intricate, incorporating cutting-edge materials, electronics, and software. Testing these sophisticated devices demands specialized expertise, sophisticated equipment, and advanced methodologies, which can substantially drive up testing costs and duration. Furthermore, the intricacy of these devices poses challenges in ensuring their safety and efficacy, making it critical to develop and apply equally complex testing procedures. This complexity adds to the regulatory burden and can hinder innovation and market entry, impacting the overall efficiency and competitiveness of the medical device testing process.

Opportunity:

Rising healthcare expenditure

Increased healthcare budgets result in higher investments in medical device research, development, and manufacturing. This, in turn, fuels the demand for comprehensive testing services to ensure that these devices meet stringent quality and safety standards. As healthcare systems allocate more resources to technological advancements and device innovation, the need for rigorous testing to verify the functionality and safety of these devices becomes paramount. This growing financial commitment to healthcare infrastructure and medical technology offers a promising landscape for companies specializing in medical device testing, creating opportunities for expansion and innovation in the market.

Threat:

Limited access to skilled personnel

The industry demands a highly specialized workforce with expertise in various scientific and technical disciplines, including clinical research, quality assurance, data analysis, and regulatory affairs. The shortage of qualified professionals can hinder the efficient and accurate execution of tests and trials, potentially leading to delays in product development and market entry. Furthermore, it can result in increased operational costs and quality control challenges, ultimately affecting the competitiveness and credibility of medical device testing companies.

COVID-19 Impact:

The COVID-19 pandemic has had a positive impact on the medical device testing market. With a heightened focus on healthcare and the urgent need for diagnostic and therapeutic devices, the demand for efficient and reliable testing solutions surged. Medical device testing played a crucial role in ensuring the safety and effectiveness of products like ventilators, diagnostic kits, and PPE. Additionally, the pandemic accelerated the development and regulatory approval of new medical devices, leading to increased demand for testing services. This unforeseen global health crisis underscored the importance of rigorous testing and quality assurance, resulting in a growing market for medical device testing.

The active implant medical devices segment is expected to be the largest during the forecast period

The active implant medical devices segment is expected to have lucrative growth. These devices, such as cardiac pacemakers, neurostimulators, and implantable defibrillators, require meticulous testing to validate their safety, functionality, and compatibility with the human body. Testing encompasses assessments of electronic systems, battery performance, biocompatibility, and electromagnetic compatibility. Ensuring the reliability and long-term safety of these implantable devices is paramount as they directly affect patient well-being.

The consumers and patients segment is expected to have the highest CAGR during the forecast period

The consumers and patients segment is anticipated to witness the fastest CAGR growth during the forecast period. With the growing focus on patient safety, consumers, and patients are becoming more informed and discerning about the medical devices they use. This increased awareness is driving demand for stringent testing to ensure the safety and efficacy of devices. Additionally, the rise in direct-to-consumer medical devices and home healthcare equipment further emphasizes the need for robust testing to build trust among end-users. As the empowered healthcare consumer trend continues to gain momentum, the Consumers and Patients segment is poised for substantial growth.

Region with largest share:

North America holds a significant share in the market over the forecast period. The region boasts a well-established healthcare industry, advanced research infrastructure, and stringent regulatory frameworks. North American countries, particularly the United States, host a plethora of medical device manufacturers and research organizations, fueling the demand for testing services to ensure product compliance with regulatory standards. The market benefits from a robust ecosystem of accredited testing laboratories, clinical trial facilities, and regulatory experts, making it an attractive destination for both domestic and international medical device companies seeking rigorous and reliable testing, certification, and validation services.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's expanding healthcare sector, increasing investments in research and development, and growing demand for medical devices have fuelled the need for comprehensive testing services. With the rising awareness of healthcare quality and safety, Asia Pacific countries are enhancing their regulatory and quality standards, driving the demand for testing to ensure product compliance and safety. Additionally, the availability of a skilled workforce, cost-effective clinical trials, and a diverse patient population make Asia Pacific an attractive destination for medical device manufacturers looking to conduct clinical studies and tests.

Key players in the market

Some of the key players in Medical Device Testing market include: Avomeen, BSI Group, Bureau Veritas, Dekra Testing and Certification GmbH, Element Materials Technology, Eurofins Scientific, Gateway Analytical LLC, Intertek Group PLC, Medistri SA, Pace Analytical Services LLC, SGS SA, TUV Rheinland and WuXi AppTec.

Key Developments:

In June 2023, TUV SUD has opened a laboratory in New Brighton, Minnesota, accredited to ISO 17025 for biological and chemical testing of medical devices. Staffed by experienced scientists and technicians, the lab will cater to both domestic and international medical device companies, aiding in research and development through microbiology, reusable device testing, chemistry, biocompatibility, and packaging testing services.

In September 2022, Bureau Veritas has acquired Galbraith Laboratories Inc., known for advanced analytical solutions in healthcare. This acquisition amplifies Bureau Veritas' presence in Consumer Healthcare and Industrial Chemicals supply chains, bolstering support for research, development, and product testing. Galbraith Laboratories' expertise will enhance Bureau Veritas' service portfolio, particularly in medical device testing, expanding its reach and influence in the US.

Products Covered:

• Active Implant Medical Devices
• Non-active Medical Devices
• In Vitro Diagnostic (IVD) Medical Devices
• Ophthalmic Medical Devices
• Orthopedic Medical Devices
• Vascular Medical Devices
• Other Products

Service Types Covered:

• Testing Services
• Inspection Services
• Certification Services
• Other Service Types

Sourcing Types Covered:

• In-house
• Outsourced

Device Classes Covered:

• Class I
• Class II
• Class III
• Other Device Classes

End Users Covered:

• Academic and Research Institutions
• Consumers and Patients
• Healthcare Professionals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances